(HealthDay)—The American Academy of Neurology's (AAN's) Top Five Recommendations in the Choosing Wisely campaign, established to promote high-value neurologic medicine and to foster physician-patient communication, have ...
Feb 25, 2013
0
0
(HealthDay)—Corticorelin acetate (CrA) administration to patients with peritumoral brain edema (PBE) allows the reduction of steroid doses and is associated with reduced incidence and severity of steroid-induced myopathy ...
Feb 6, 2013
0
0
(HealthDay)—Use of the injectable contraceptive depot medroxyprogesterone acetate (MPA), common in areas such as sub-Saharan Africa with high HIV-1 prevalence, is associated with suppression of the immune response, according ...
Feb 1, 2013
0
0
(HealthDay)—For chemotherapy-naive patients with metastatic castration-resistant prostate cancer, abiraterone acetate correlates with improved radiographic progression-free survival, according to a study published online ...
Dec 12, 2012
0
0
(Medical Xpress)—Multiple sclerosis (MS) patients sometimes experience "natural" improvements in disability at least over the short term, according to a new study led by researchers at the University of British Columbia ...
Oct 18, 2012
0
0
(HealthDay)—The number of meningitis cases linked to apparently contaminated steroid injections has risen to 91 in nine states, and the number of deaths remains at seven, U.S. health officials reported Sunday.
Oct 8, 2012
0
0
(AP)—Health providers scrambled to notify patients in nearly two dozen U.S. states that the steroid injections they received for back pain may have been contaminated with a deadly fungal meningitis. Five people have died.
Oct 5, 2012
0
0
(AP)—A fifth person has died in a growing outbreak of a rare form of meningitis that has sickened more than two dozen people in five U.S. states.
Oct 4, 2012
0
0
(HealthDay)—The risk of venous thromboembolism (VTE) in postmenopausal women differs considerably according to the formulation of hormone therapy (HT) used, with the highest VTE risk seen in users of oral estrogen-progestin ...
Sep 18, 2012
0
0
Results of a phase 3 trial published in The Lancet Oncology have confirmed that the drug abiraterone acetate (marketed as Zytiga) offers a significant survival benefit to patients with castration-resistant prostate cancer, ...
Sep 17, 2012
0
0
